SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-015499
Filing Date
2021-03-25
Accepted
2021-03-25 16:18:21
Documents
12
Period of Report
2021-03-19
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20210319.htm   iXBRL 8-K 34222
  Complete submission text file 0001564590-21-015499.txt   167262

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA odt-20210319.xsd EX-101.SCH 5769
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20210319_lab.xml EX-101.LAB 20214
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20210319_pre.xml EX-101.PRE 12079
5 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20210319_htm.xml XML 3683
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 21772599
SIC: 2834 Pharmaceutical Preparations